Vertex Pharmaceuticals Incorporated (VRTX) Stock Overview
NASDAQ · Healthcare · Biotechnology
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated operates as a biotechnology company in the United States, Europe, and internationally. The company offers transformative medicines for people with serious diseases with a focus on specialty markets, such as cystic fibrosis (CF), sickle cell disease (SCD),…
Source: Yahoo Finance
Sector & Industry
Vertex Pharmaceuticals Incorporated operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Vertex Pharmaceuticals Incorporated at a Glance
| Company | Vertex Pharmaceuticals Incorporated |
| Ticker | VRTX |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $485.65 |
| Market cap | $123.26B |
| P/E ratio (trailing) | 28.82 |
| EPS (trailing) | $16.85 |
| 52-week high | $533.67 |
| 52-week low | $362.50 |
| Dividend yield | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 6,400 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
What is Vertex Pharmaceuticals Incorporated's P/E ratio?
Vertex Pharmaceuticals Incorporated (VRTX) has a trailing P/E ratio of 28.82 as of our latest data snapshot.
What is Vertex Pharmaceuticals Incorporated's market cap?
Vertex Pharmaceuticals Incorporated's market capitalisation is $123.26B based on the most recent snapshot.
What is VRTX's 52-week range?
Over the past 52 weeks, VRTX has traded between $362.50 and $533.67.
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →A dedicated finance calculator for TVM, NPV and rate-of-return work.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →Related Healthcare Stocks
Data snapshot: 18 July 2026 (Yahoo Finance) · Page last built: